The Prevalence of Familial Hypercholesterolemia (FH) in Chinese Patients With Acute Myocardial Infarction (AMI): Data From Chinese Acute Myocardial Infarction (CAMI) Registry-Reference-Cited by-同舟云学术

The Prevalence of Familial Hypercholesterolemia (FH) in Chinese Patients With Acute Myocardial Infarction (AMI): Data From Chinese Acute Myocardial Infarction (CAMI) Registry

Published:2020-07-16 Issue: Volume:7 Page:
ISSN:2297-055X
Container-title:Frontiers in Cardiovascular Medicine
language:
Short-container-title:Front. Cardiovasc. Med.

Author:

Shi Hui-Wei,Yang Jin-Gang,Wang Yang,Li Wei,Guo Yuan-Lin,Gao Ying,Tang Yi-Da,Li Jian-Jun,Wu Na-Qiong,Yang Yue-Jin

Publisher

Frontiers Media SA

Subject

Cardiology and Cardiovascular Medicine

Reference33 articles.

1. The genetics and screening of familial hypercholesterolaemia;Henderson;J Biomed Sci.,2016

2. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society;Nordestgaard;Eur Heart J.,2013

3. Prevalence and management of familial hypercholesterolaemia in patients with acute coronary syndromes;Nanchen;Eur Heart J.,2015

4. Prevalence and management of familial hypercholesterolaemia in coronary patients: an analysis of EUROASPIRE IV, a study of the European Society of Cardiology;De Backer;Atherosclerosis.,2015

5. Familial hypercholesterolemia phenotype in Chinese patients undergoing coronary angiography;Li;Arterioscler Thromb Vasc Biol.,2017

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiovascular Risk Factors in China;Journal of Geriatric Cardiology;2024-02

2. The prevalence and treatment patterns of familial hypercholesterolemia among Thai patients with premature coronary artery disease;Postgraduate Medicine;2023-02-27

3. Landscape of cardiometabolic risk factors in Chinese population: a narrative review;Cardiovascular Diabetology;2022-06-21

4. The Progression of Treatment for Refractory Hypercholesterolemia: Focus on the Prospect of Gene Therapy;Frontiers in Genetics;2022-06-09

5. Heterozygous familial hypercholesterolemia: prevalence and control rates;Expert Review of Endocrinology & Metabolism;2021-05-17